Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-038676
Filing Date
2024-08-28
Accepted
2024-08-28 16:30:23
Documents
4
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724877016.html 4  
1 FORM 4 wk-form4_1724877016.xml 4 6171
2 EX-24 exhibit24bothapoa.htm EX-24 4366
3 exhibit24bothapoa001.jpg GRAPHIC 247294
4 exhibit24bothapoa002.jpg GRAPHIC 34444
  Complete submission text file 0001628280-24-038676.txt   400419
Mailing Address C/O SEQUOIA CAPITAL 2800 SAND HILL RD, SUITE 101 MENLO PARK CA 94025
Business Address
BOTHA ROELOF (Reporting) CIK: 0001222287 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 241255922

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)